-
公开(公告)号:US06541515B2
公开(公告)日:2003-04-01
申请号:US09925114
申请日:2001-08-09
申请人: Sheo Bux Singh , Hiranthi Jayasuriya , Ziqiang Guan , Keith C. Silverman , Russell B. Lingham , Anne W. Dombrowski , Daria J. Hazuda , Jon D. Polishook
发明人: Sheo Bux Singh , Hiranthi Jayasuriya , Ziqiang Guan , Keith C. Silverman , Russell B. Lingham , Anne W. Dombrowski , Daria J. Hazuda , Jon D. Polishook
IPC分类号: A61K31215
CPC分类号: C07C62/38 , C07C69/753 , C07C2602/28
摘要: Compounds useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines are described. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. The culture Cytospora sp. MF 6608 (ATCC PTA-1691) is also disclosed, as well as processes for making a compound of the present invention employing the culture.
摘要翻译: 可用于抑制HIV整合酶,预防或治疗艾滋病毒感染和治疗艾滋病的化合物,无论是否与其他抗病毒药,免疫调节剂,抗生素或疫苗结合使用,化合物,药学上可接受的盐,药物组合物成分均为 描述。 还描述了治疗艾滋病的方法和预防或治疗HIV感染的方法。 培养Cytospora sp。 还公开了MF 6608(ATCC PTA-1691),以及使用培养物制备本发明化合物的方法。
-
公开(公告)号:US20110065087A1
公开(公告)日:2011-03-17
申请号:US12739186
申请日:2008-10-20
申请人: Amy S. Espeseth , Daria J. Hazuda , Min Xu , Honglin Zhou
发明人: Amy S. Espeseth , Daria J. Hazuda , Min Xu , Honglin Zhou
CPC分类号: C12N9/1241 , C12N15/111 , C12N15/1132 , C12N2310/14 , C12N2320/12
摘要: A set of cellular genes that were identified by siRNA screening as being essential for Human Immunodeficiency Virus (HIV) infection. These genes are host cellular factors involved in DNA repair, specifically in the base excision repair pathway.
摘要翻译: 通过siRNA筛选鉴定为对人类免疫缺陷病毒(HIV)感染至关重要的一组细胞基因。 这些基因是涉及DNA修复的宿主细胞因子,特别是在基础切除修复途径中。
-
公开(公告)号:US20090221679A1
公开(公告)日:2009-09-03
申请号:US11990174
申请日:2006-08-08
申请人: Amy Espeseth , Daria J. Hazuda , Min Xu
发明人: Amy Espeseth , Daria J. Hazuda , Min Xu
IPC分类号: A61K31/7088 , C40B30/04 , C12Q1/70
CPC分类号: C12N15/1093 , C12N15/111 , C12N2310/14 , C12N2320/12 , C12N2330/31
摘要: Using a method to measure the effect of downregulation of certain cellular proteins on HIV integration, host proteins implicated in HIV infection were identified. The identified proteins and encoding nucleic acids provide targets for inhibiting HIV infection and for evaluating the ability of compounds to inhibit HIV infection. Compounds inhibiting HIV infection include compounds targeting identified proteins and compounds targeting nucleic acids encoding the proteins.
摘要翻译: 使用一种方法来测量某些细胞蛋白下调对HIV整合的影响,鉴定了涉及HIV感染的宿主蛋白。 鉴定的蛋白质和编码核酸提供了抑制HIV感染和评估化合物抑制HIV感染能力的目标。 抑制HIV感染的化合物包括靶向鉴定的蛋白质的化合物和靶向编码蛋白质的核酸的化合物。
-
公开(公告)号:US07744887B2
公开(公告)日:2010-06-29
申请号:US11628164
申请日:2005-05-31
申请人: John W. Shiver , Michael D. Miller , Romas Geleziunas , Daria J. Hazuda , Peter S. Kim , Debra M. Eckert , Michael J. Root , Simon N. Lennard , Elisabetta Bianchi
发明人: John W. Shiver , Michael D. Miller , Romas Geleziunas , Daria J. Hazuda , Peter S. Kim , Debra M. Eckert , Michael J. Root , Simon N. Lennard , Elisabetta Bianchi
IPC分类号: A61K39/42 , G01N33/53 , A61K39/395 , C12P16/00
CPC分类号: G01N33/56988 , C07K16/1063 , C07K2317/21 , C07K2317/622 , C07K2317/76 , G01N2500/00
摘要: Human scFvs are disclosed which interact with a conformational epitope along the pre-hairpin, N-helix coiled coil structure within the heptad repeat 1 (HR1) region of gp41 of HIV. These antibodies, as well as IgG conversions, are shown to neutralize diverse HIV isolates. Isolated nucleic acid molecules are also disclosed which encode relevant portions of these antibodies, as well as the purified forms of the expressed antibodies or relevant antibody fragments, such as VH and VL chains. The antibody compositions disclosed within this specification may provide for a therapeutic treatment against HIV infection by reducing viral load levels within an infected individual, thus prolonging the asymptomatic phase of HIV infection. These antibodies will also be useful in assays to identify HIV antiviral compounds as well as allowing for the identification of candidate HIV vaccines, such as HIV peptide vaccines.
摘要翻译: 披露了人scFv,其与艾滋病病毒gp41的七重复重复1(HR1)区域内的前发夹,N-螺旋卷曲螺旋结构与构象表位相互作用。 显示出这些抗体以及IgG转化中和多种HIV分离物。 还公开了分离的核酸分子,其编码这些抗体的相关部分,以及所表达的抗体或相关抗体片段(例如VH和VL链)的纯化形式。 在本说明书中公开的抗体组合物可通过降低受感染个体内的病毒载量水平来提供抗HIV感染的治疗性治疗,从而延长HIV感染的无症状期。 这些抗体也可用于鉴定HIV抗病毒化合物的测定,以及允许鉴定候选的HIV疫苗,例如HIV肽疫苗。
-
公开(公告)号:US20100324034A1
公开(公告)日:2010-12-23
申请号:US12526437
申请日:2008-02-08
IPC分类号: A61K31/167 , A61P31/18 , A61K31/536 , A61K31/496 , A61K31/513
CPC分类号: A61K31/19 , A61K31/167 , A61K31/496 , A61K31/506 , A61K31/536 , A61K45/06 , A61K2300/00
摘要: The present invention relates to pharmaceutical preparations and methods for treating individuals infected with the human immunodeficiency virus (HIV). The pharmaceutical preparations comprise SAHA and another anti-viral agent. The invention also relates to methods for treating HIV infected patients, particularly patients with persistent, latent HIV infection of CD4+ T cells, and thus make it possible to not just suppress but to eradicate the HIV infection.
摘要翻译: 本发明涉及用于治疗感染人类免疫缺陷病毒(HIV)的个体的药物制剂和方法。 药物制剂包含SAHA和另一种抗病毒剂。 本发明还涉及用于治疗HIV感染的患者,特别是CD4 + T细胞持续的,潜伏的HIV感染的患者的方法,因此使得不仅可以抑制HIV消除HIV感染。
-
-
-
-